Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial

作者：Elias Jabbour, Federico Lussana, Pilar Martínez‐Sánchez, Anna Torrent, J. Rifón, Vaibhav Agrawal, Mar Tormo, Ryan D. Cassaday, Thomas Cluzeau, Françoise Huguet, Cristina Papayannidis, Jesús María Hernández‐Rivas, Anita W. Rijneveld, Shaun Fleming, Vladan Vučinić, Boris Böll, Takayuki Ikezoe, Maher Abdul‐Hay, Mary Lynn Savoie, Andre C. Schuh, Céline Berthon, Stefan Schwartz, Sabina Chiaretti, Junichiro Yuda, Takuya Miyazaki, José González‐Campos, Yuqi Chen, Hansen Wong, Jessica Choudhry, Gerhard Zugmaier, Erin Guest, Paul Gordon, Hagop M. Kantarjian · 发表于：The Lancet Haematology · 年份：2025 · DOI：10.1016/s2352-3026(25)00144-9 · 被引用次数：17 · 研究领域：Acute Lymphoblastic Leukemia research、Lymphoma Diagnosis and Treatment、CAR-T cell therapy research